Co-administration of CD40 agonistic antibody and antigen fails to overcome the induction of oral tolerance

Immunology

Volumn 111, Issue 1, 2004, Pages 19-26

  Chung, Yeonseok ^a   Kim, Dong Hyeon ^a   Lee, Seung Ho ^a   Kang, Chang Yuil ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD40 ANTIBODY; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIVISION; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; IMMUNOLOGICAL TOLERANCE; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; IMMUNE TOLERANCE; INTESTINES; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OVALBUMIN;

EID: 0347756828     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01787.x     Document Type: Article

References (43)

1. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233-58.
2. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996; 14:591-617.
3. Legge KL, Gregg RK, Maldonado-Lopez R, Li L, Caprio JC, Moser M, Zaghouani H. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J Exp Med 2002; 196:217-27.
4. Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194:769-79.
5. Garza KM, Chan SM, Suri R, Nguyen LT, Odermatt B, Choenberger SSP, Ohashi PS. Role of antigen presenting cells in mediating tolerance and autoimmunity. J Exp Med 2000; 191:2021-7.
6. Maxwell JR, Campbell JD, Kim CH, Vella AT. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J Immunol 1999; 162:2024-34.
7. Grohmann U, Fallarino F, Silla S et al. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells. J Immunol 2001; 166:277-83.
8. Ichikawa HT, Williams LP, Segal BM. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J Immunol 2002; 169:2781-7.
9. Sotomayor EM, Borrello I, Tubb E et al. Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nat Med 1999; 5:780-7.
10. French RR, Chan HT, Tutt AL, Glennie MJ. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat Med 1999; 5:548-53.
11. Lefrancois L, Altman JD, Williams K, Olson S. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J Immunol 2000; 164:725-32.
12. Diehl L, den Boer AT, Schoenberger SP, van der Voort EI, Schumacher TN, Melief CJ, Offringa R, Toes RE. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med 1999; 5:774-9.
13. Hiroi T, Goto H, Someya K, Yanagita M, Honda M, Yamanaka N, Kiyono HHIV Mucosal Vaccine. Nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1- and Th2-deficient conditions. J Immunol 2001; 167:5862-7.
14. Iijima H, Takahashi I, Kiyono H. Mucosal immune network in the gut for the control of infectious diseases. Rev Med Virol 2001; 11:117-33.
15. Weiner HL, Friedman A, Miller A et al. Oral tolerance, immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12:809-37.
16. Chung Y, Choi J, Chang Y-S, Cho S-H, Kang C-Y. Preventive and therapeutic effects of oral tolerance in a murine model of asthma. Immunobiology 2002; 206:408-23.
17. Weiner HL, Mackin GA, Matsui M, Khoury EJ, Dawson DM, Hafler DA. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259:1321-4.
18. Trentham DE, Dyneisius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Swell KL, Hafler DA, Weiner HL. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261:1727-30.
19. Pooley JL, Heath WR, Shortman K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol 2001; 166:5327-30.
20. Chung Y, Chang SY, Kang CY. Kinetic analysis of oral tolerance: memory lymphocytes are refractory to oral tolerance. J Immunol 1999; 163:3692-8.
21. Mintern J, Li M, Davey GM, Blanas E, Kurts C, Carbone FR, Heath WR. The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo. Immunol Cell Biol 1999; 77:539-43.
22. Blanas E, Davey GM, Carbone FR, Heath WR A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol 2000; 164:2890-6.
23. Lee HO, Cooper CJ, Choi JH, Alnadjim Z, Barrett TA. The state of CD4+ T cell activation is a major factor for determining the kinetics and location of T cell responses to oral antigen. J Immunol 2002; 168:3833-8.
24. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
25. Watts C. Immunology Inside the gearbox of the dendritic cell. Nature 1997; 388:724-5.
26. Gilliet M, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002; 195:695-704.
27. Gabrielle TB, Behrens GMN, Smith CM et al. The CD8+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 2002; 196:1099-104.
28. Maldonado-López R, De Smedt T, Michel P et al. CD8α+ and CD8α- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999; 189:587-92.
29. Samoilova EB, Horton JL, Zhang H, Khoury SJ, Weiner HL, Chen Y. CTLA-4 is required for the induction of high dose oral tolerance. Int Immunol 1998; 10:491-8.
30. Wakkach A, Fournier N, Brun V, Breittmayer J-P, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18:605-17.
31. s cells, the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002; 3:237-43.
32. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16:137-67.
33. Moore KW, Malefyt R de Waal, Coffman RL, O'Garra A Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-65.
34. Perez VL, Parijs L Van, Biuckians A, Zheng XX, Strom TB, Abbas AK. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997; 6:411-7.
35. Carreno BM, Collins M. The B7 family of ligands and its receptors, new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002 1997; 20:29-53.
36. Greenwald RJ, Latchman YE, Sharpe AH. Negative co-receptors on lymphocytes. Curr Opin Immunol 2002; 14:391-6.
37. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23:445-9.
38. Menges M, Rößner S, Voigtländer C et al. Repetitive injections of dendritic cells matured with tumor necrosis factor-α induce antigen-specific protection of mice from autoimmunity. J Exp Med 2001; 195:15-21.
39. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol 2001; 2:725-31.
40. Albert ML, Jegathesan M, Darnell RB. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2001; 2:1010-7.
41. Curtsinger JM, Lins DC, Mescher MF. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 2003; 197:1141-51.
42. Deeths MJ, Kedl RM, Mescher MF. CD8+ T cells become non-responsive (anergic) following activation in the presence of costimulation. J Immunol 1999; 163:102-10.
43. Sun J, Houten NV. CD40 stimulation in vivo does not inhibit CD4 T cell tolerance to soluble antigens. Immunol Letter 2002; 84:125-32.